Bayliss George
Division of Kidney Diseases and Hypertension, APC 9, Rhode Island Hospital, 593 Eddy St., Providence, RI 02906, USA.
Cardiovasc Hematol Disord Drug Targets. 2014;14(3):165-9. doi: 10.2174/1871529x14666140401111115.
A paradigm shift is occurring in the way nephrologists evaluate patients with progressive chronic kidney disease for initiation of maintenance renal replacement therapy. Serum creatinine and serum creatinine-based equations used to calculate an estimated glomerular filtration rate (eGFR) are not accurate approximations of renal function at low levels. Further complicating matters is a trend toward early initiation of dialysis, once considered beneficial since patients had better outcomes if they started dialysis before the onset of protein malnutrition. But recent data, including results of a large randomized controlled trial, suggest no benefit and possibly increased risk of death with early initiation of dialysis. This review will examine the data and where the field stands in deciding when to initiate dialysis.
肾脏病学家评估进行性慢性肾脏病患者以启动维持性肾脏替代治疗的方式正在发生范式转变。血清肌酐以及用于计算估算肾小球滤过率(eGFR)的基于血清肌酐的公式,在低水平时并非肾功能的准确近似值。使情况更加复杂的是,透析早期启动的趋势,曾经认为这是有益的,因为如果患者在蛋白质营养不良发作之前开始透析,他们会有更好的结果。但最近的数据,包括一项大型随机对照试验的结果,表明早期启动透析没有益处,甚至可能增加死亡风险。本综述将审视这些数据以及该领域在决定何时开始透析方面的现状。